Atracurium Besylate Injection, Solution
Product Images NDC 71288-701
Product Visual Gallery
This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Atracurium Besylate (NDC 71288-701). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Meitheal Pharmaceuticals Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Principal Display Panel – Atracurium Besylate Injection, Usp 50 mg Vial Label (Atr09 0002 02)
Principal Display Panel – Atracurium Besylate Injection, Usp 50 mg Carton (Atr09 0002 03)
Principal Display Panel (Atracurium Besylate Injection, USP 100 mg Vial Label)
Principal Display Panel – Atracurium Besylate Injection, Usp 100 mg Carton (Atr09 0002 05)
* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.